中新藥業國際貿易業務擁有三十余年歷史，多年來一直堅持走中藥國際化道路。截止目前(201509)，已有163個產品在19個國家和地區注冊并銷售。“長城牌”商標在美國、香港等21個國家及地區進行了注冊，老字號商標“達仁堂”牌也于2009年進入國際市場并已在美國、香港、加拿大等8個國家及地區進行了注冊。主要出口市場為東南亞、日本、北美、澳大利亞等國家和地區，代表產品有長城清心丸、安宮牛黃丸、烏雞白鳳丸、精制銀翹解毒片等。近幾年，在中新藥業集團開拓海外市場目標的指導下，自2008年以來，公司國際貿易連續六年穩居全國中成藥出口前五強企業；2012年，入選“中醫藥國際化推進十強領軍企業”；同年，“長城牌”被授予“天津國際知名品牌”的榮譽稱號。

      The international trade of Zhongxin Pharmaceuticals has the history of more than thirty years and keeps to the internationalization of Traditional Chinese Medicine. Up to now,163 products have been registered and sold in 19 countries and regions. The trade mark“Great Wall Brand”has been registered in 21 counries such as America, Hongkong etc; the time-honored brand“Darentang”has been registered in 8 countries such as America, Canada, Hongkong etc. The major export markets are Southeast Asia, Japan, North America, Australia etc., with our representative products Changcheng Qingxin Wan, Angong Niuhuang Wan, Wuji Baifeng Wan, Jingzhi Yinqiao Jiedu Pian etc. In recent years, under the direction of overseas markets development of Zhongxin Pharmaceuticals, the international trade has been ranked as the top five in China for Chinese patent medicine export for six consecutive years since 2008; we were awarded “ Top Ten Enterprises for Internationalization of Chinese Medicine” in 2012; “Great Wall Brand” has been honored“Tianjin International Famous Brand” in the same year.